ArticleBiomolecules2025

Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced Cardiotoxicity.

Heng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.